[HTML][HTML] The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells

G Duette, B Hiener, H Morgan… - The Journal of …, 2022 - Am Soc Clin Investig
G Duette, B Hiener, H Morgan, FG Mazur, V Mathivanan, BA Horsburgh, K Fisher, O Tong…
The Journal of clinical investigation, 2022Am Soc Clin Investig
Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of CD4+ T
cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular
populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral
persistence are necessary to achieve an effective cure. In this regard, through Full-Length
Individual Proviral Sequencing, we observed that the HIV-1 proviral landscape was different
and changed with time on ART across naive and memory CD4+ T cell subsets isolated from …
Despite long-term antiretroviral therapy (ART), HIV-1 persists within a reservoir of CD4+ T cells that contribute to viral rebound if treatment is interrupted. Identifying the cellular populations that contribute to the HIV-1 reservoir and understanding the mechanisms of viral persistence are necessary to achieve an effective cure. In this regard, through Full-Length Individual Proviral Sequencing, we observed that the HIV-1 proviral landscape was different and changed with time on ART across naive and memory CD4+ T cell subsets isolated from 24 participants. We found that the proportion of genetically intact HIV-1 proviruses was higher and persisted over time in effector memory CD4+ T cells when compared with naive, central, and transitional memory CD4+ T cells. Interestingly, we found that escape mutations remained stable over time within effector memory T cells during therapy. Finally, we provided evidence that Nef plays a role in the persistence of genetically intact HIV-1. These findings posit effector memory T cells as a key component of the HIV-1 reservoir and suggest Nef as an attractive therapeutic target.
The Journal of Clinical Investigation